Holen Sie sich die Stockscreener-App
9.34
6.02%
0.53
Handel nachbörslich:
9.45
0.11
+1.18%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.81
Offen:
$8.75
24-Stunden-Volumen:
205.37K
Relative Volume:
1.67
Marktkapitalisierung:
$34.39M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.11M
KGV:
-6.1046
EPS:
-1.53
Netto-Cashflow:
$-28.18M
1W Leistung:
+32.11%
1M Leistung:
+34.39%
6M Leistung:
-22.93%
1J Leistung:
-34.69%
1-Tages-Spanne:
$8.66
$9.69
1-Wochen-Bereich:
$6.955
$9.69
52-Wochen-Spanne:
$5.3495
$28.34
Tempest Therapeutics Inc Stock (TPST) Company Profile
Firmenname
Tempest Therapeutics Inc
Sektor
Branche
Telefon
415-798-8589
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE
Vergleichen Sie TPST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
9.34 | 29.50M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-02-08 | Eingeleitet | Jefferies | Buy |
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
Pattern recognition hints at Tempest Therapeutics Inc. upsidePortfolio Return Report & Weekly High Momentum Picks - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveEarnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
What data driven models say about Tempest Therapeutics Inc.’s futureJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockJuly 2025 Momentum & AI Powered Market Trend Analysis - Newser
Analyzing drawdowns of Tempest Therapeutics Inc. with statistical toolsChart Signal and Short-Term Forecast Tracker - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoveryWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesFree Entry Alert With Low Drawdown Strategy - Newser
Is Tempest Therapeutics Inc. stock bottoming outBuy Zone Strategy with Pattern Recognition - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionFree High Return Stock Focus With Safety - Newser
Is Tempest Therapeutics Inc. a play on infrastructure spendingBottom Formation Alert - thegnnews.com
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceBuy Opportunity Forecast for Fast Traders - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.Free Risk Managed Intraday Trade Alerts - Newser
Tempest Therapeutics Reports Q2 2025 Financial Results - TipRanks
Tempest Therapeutics Inc. stock chart pattern explainedShort Squeeze Opportunities with Indicators - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyYield Curve Outlook and Long-Term Implication Summary - Newser
Tempest Therapeutics TPST 2025Q2 Earnings Preview Downside Risk Amid Uncertain Revenue Expectations - AInvest
Tempest Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tempest Therapeutics reports Q2 EPS ($2.07), consensus ($2.65) - TipRanks
Tempest Therapeutics: A Case Study in Operational Turnaround and Biotech Resilience - AInvest
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Is it too late to sell Tempest Therapeutics Inc.Pattern Recognition Tool for ROI Investors - Newser
Tempest Therapeutics Inc. stock outlook for YEARFree Smart Trade Plans With Risk Protection - Newser
Real time alert setup for Tempest Therapeutics Inc. performanceInvestment Life Cycle Planning Summary - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comeback - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Short Term Gain Strategy with AI Logic - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayROI Focused Setup Screener With Exit Markers - Newser
Published on: 2025-08-09 23:28:19 - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
Tempest Therapeutics Inc expected to post a loss of $2.60 a shareEarnings Preview - TradingView
Tempest Therapeutics (TPST) Expected to Announce Quarterly Earnings on Thursday - Defense World
Long term hold vs stop loss in Tempest Therapeutics Inc.Smart Forecast Signals from AI Models - Newser
Finanzdaten der Tempest Therapeutics Inc-Aktie (TPST)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):